FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person *   Chari Ravi S. 2. Date of Event Requiring Statement (Month/Day/Year) 01/29/2015 3. Issuer Name and Ticker or Trading Symbol HCA Holdings, Inc. [HCA] (Last) (First) (Middle) ONE PARK PLAZA 4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) SVP-Clinical Excellence 5. If Amendment, Date Original Filed(Month/Day/Year) (Street) NASHVILLE, TN 37203 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Beneficially Owned

1.Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5) Common Stock 5,562.6529 (1) D Â

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.			SEC 1473 (7-02)
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	  (2)	02/25/2019	Common Stock	1,964	$ 11.3585	D	Â
Non-Qualified Stock Option (right to buy)	02/25/2010	02/25/2019	Common Stock	1,964	$ 7.4739	D	Â
Non-Qualified Stock Option (right to buy)	  (2)	08/27/2019	Common Stock	2,252	$ 15.9112	D	Â
Non-Qualified Stock Option (right to buy)	  (3)	08/27/2019	Common Stock	1,304	$ 6.4772	D	Â
Non-Qualified Stock Option (right to buy)	  (4)	08/27/2019	Common Stock	2,254	$ 5.9821	D	Â
Non-Qualified Stock Option (right to buy)	08/27/2010	08/27/2019	Common Stock	2,252	$ 10.9168	D	Â
Non-Qualified Stock Option (right to buy)	08/27/2011	08/27/2019	Common Stock	2,252	$ 6.4772	D	Â
Non-Qualified Stock Option (right to buy)	  (5)	08/27/2019	Common Stock	4,505	$ 5.9821	D	Â
Non-Qualified Stock Option (right to buy)	11/02/2012	11/02/2021	Common Stock	3,125	$ 21.35	D	Â
Non-Qualified Stock Option (right to buy)	  (6)	11/02/2021	Common Stock	9,375	$ 17.33	D	Â
Non-Qualified Stock Option (right to buy)	  (7)	11/02/2021	Common Stock	2,500	$ 22.1	D	Â
Non-Qualified Stock Option (right to buy)	  (8)	11/02/2021	Common Stock	6,250	$ 17.33	D	Â
Stock Appreciation Right	  (9)	02/08/2022	Common Stock	5,000	$ 22.95	D	Â
Stock Appreciation Right	  (10)	02/08/2022	Common Stock	5,000	$ 22.95	D	Â
Stock Appreciation Right	  (11)	02/08/2022	Common Stock	5,000	$ 22.95	D	Â
Stock Appreciation Right	  (12)	02/06/2023	Common Stock	2,125	$ 37.18	D	Â
Stock Appreciation Right	02/06/2014	02/06/2023	Common Stock	2,125	$ 37.18	D	Â
Stock Appreciation Right	  (13)	02/06/2023	Common Stock	6,375	$ 37.18	D	Â
Stock Appreciation Right	  (14)	02/05/2024	Common Stock	7,000	$ 47.97	D	Â
Restricted Stock Units	  (15)	02/08/2022	Common Stock	1,226	$ (16)	D	Â
Restricted Stock Units	  (17)	02/06/2023	Common Stock	1,688	$ (16)	D	Â
Restricted Stock Units	  (18)	02/05/2024	Common Stock	2,000	$ (16)	D	Â

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Chari Ravi S. ONE PARK PLAZA NASHVILLE, TN 37203	Â	Â	  SVP-Clinical Excellence	Â

Signatures

/s/ Kevin A. Ball, Attorney-in-Fact		02/06/2015
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 99.6529 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
(2)	The option vested at the end of fiscal year 2009 based upon the achievement of certain annual EBITDA performance targets.
(3)	The option vested in two equal installments at the end of fiscal years 2010 and 2011 based upon the achievement of certain annual EBITDA performance targets.
(4)	The option vested in equal increments (i) at the end of fiscal year 2012 upon the achievement of certain annual EBITDA performance targets and (ii) upon a change in control (as defined in the 2006 Stock Incentive Plan for Key Employees of HCA Holdings, Inc. and its Affiliates as Amended and Restated) of the Issuer which occurred effective November 1, 2013.
(5)	The option was scheduled to vest in three equal annual installments beginning on August 27, 2012. A change in control of the Issuer occurred effective November 1, 2013, resulting in the accelerated vesting of the option as to the shares that remained unvested.
(6)	The option vests in three equal annual installments beginning on November 2, 2013.
(7)	The option vested at the end of fiscal year 2011 based upon the achievement of certain annual EBITDA performance targets.
(8)	On November 2, 2011, the reporting person was granted an option to purchase 9,375 shares of common stock. The option vests in equal increments at the end of fiscal years 2012, 2013 and 2014 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. The EBITDA performance criteria for 2012 and 2013 was met, resulting in vesting of the option as to 6,250 shares.
(9)	On February 8, 2012, the reporting person was granted 10,000 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2012, 2013, 2014 and 2015 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2012 and 2013 was met, resulting in the vesting of 5,000 stock appreciation rights.
(10)	The stock appreciation rights vested in two equal annual installments beginning on February 8, 2013.
(11)	The stock appreciation rights vest in two equal annual installments beginning on February 8, 2015.
(12)	On February 6, 2013, the reporting person was granted 8,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year. EBITDA performance criteria for 2013 was met, resulting in the vesting of 2,125 stock appreciation rights.
(13)	The stock appreciation rights vest in three equal annual installments beginning on February 6, 2015.
(14)	The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.
(15)	The restricted stock units vest in two equal annual installments beginning February 8, 2015.
(16)	Each restricted stock unit represents a contingent right to receive one share of HCA Holdings, Inc. common stock.
(17)	The restricted stock units vest in three equal annual installments beginning February 6, 2015.
(18)	The restricted stock units vest in four equal annual installments beginning February 5, 2015.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.